Printer Friendly

BSD REPORTS FINANCIAL RESULTS 2nd Qtr FISCAL 2013.

BSD Medical Corporation a provider of medical systems that treat cancer and benign diseases using heat therapy, has reported financial results for its second quarter and first six months of fiscal 2013, including:

Total revenues of $1.5 million for the six months ended February 28, 2013 compared to total revenues of $0.9 million for the same period a year ago

Total revenues of $0.8 million for the second quarter ended February 28, 2013 compared to total revenues of $0.3 million of the second quarter of last year

Total Hyperthermia backlog of approximately $0.8 million

Net loss of $1.9 million for the three months ended February 28, 2013 compared to a net loss of $2.1 million for the three months ended February 29, 2012

Net cash used in operating activities was $1.4 million for the three months ended February 28, 2013 and $3.4 million for the six months ended February 28, 2013

Cash and cash equivalents of $7.7 million

No debt

Total stockholders' equity of $11.0 million

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD's product lines include both hyperthermia and ablation treatment systems. BSD's hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other

therapies such as radiation therapy. BSD's microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue.

For more information visit www.BSDMedical.com or call 801-972-5555.
COPYRIGHT 2013 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Financial Reports
Article Type:Financial report
Date:May 1, 2013
Words:284
Previous Article:Synthetic Biologics Sells Clinical Reference Lab.
Next Article:IHS REPORTS SOFT GROWTH IN 2012 MEMS MARKET.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |